Shattuck Labs
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 months.
- Its last 3 Sell calls were followed by roughly flat moves (-2%) three months out.
- Recent price momentum is +46.3% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Operating margin | -5,150.8% | Better than 1% |
| Net margin | -4,880.9% | Better than 1% |
| Return on equity | -60.3% | Better than 8% |
| Return on invested capital | -61.4% | Better than 5% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -40.8% | Better than 10% |
| 6-month return | -26.9% | Better than 21% |
| 12-month return (ex latest month) | 175.9% | Better than 99% |
| Distance below 52-week high | 46.5% | Better than 22% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 11.7x | Better than 95% |
| Debt to assets | 2.7% | Better than 86% |
| Interest coverage | -1.8x | Better than 20% |
Analyst View A+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 242.8% | Better than 96% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 4.55
- Open
- 4.48
- Day range
- 4.42 - 4.68
- Avg price
- 4.49
- Volume
- 1.03M
- Turnover
- 4.63M
- Turnover ratei
- 1.40%
- Volume ratioi
- 0.81
- Amplitudei
- 5.71%
- 52-week rangei
- 1.93 - 8.33
Valuation
- P/Ei
- -6.37
- P/E (TTM)i
- -9.49
- P/Bi
- 2.34
- EPSi
- -0.70
- Book value / shi
- 1.90
- Net profit
- -71.29M
- Net assets
- 193.70M
Share structure
- Market cap
- 454.22M
- Float capi
- 328.97M
- Shares out
- 101.84M
- Float sharesi
- 73.76M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-10-09
46.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+978.33K net over the window
Short interest
- Shares short
- 10.75M
- % of floati
- 10.71%
- Days to coveri
- 11.97
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Shattuck Labs (STTK)?
Shattuck Labs last traded at 4.46. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Shattuck Labs's market cap?
About 454.22M.
What is the P/E ratio of Shattuck Labs?
The trailing twelve-month P/E is -9.49. The Valuation tab shows it against the stock's own five-year range.
Does Shattuck Labs pay a dividend?
Shattuck Labs does not currently pay a regular dividend.
Is Shattuck Labs a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 15.29, which implies 242.8% upside from the current price. This is not investment advice.
What is Shattuck Labs's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Shattuck Labs a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Shattuck Labs discussion 0 comments